Personalized Immunotherapy Vaccine for Pancreatic Cancer
Researchers are creating personalized vaccines to stimulate a pancreatic cancer patient’s immune system after surgery and chemotherapy.
Targeting Tumor Proteins Specific to Pancreatic Cancer Cells
A clinical trial tests the safety and effectiveness of tumor-associated antigen-specific cytotoxic T lymphocytes, which target specific tumor proteins.
Testing Immunotherapy for Safety Before and After Pancreatic Cancer Removal
Researchers are testing a new monoclonal antibody to see if it helps patients with pancreatic tumors that can be surgically removed.
Testing a Breast Cancer Drug for Other Advanced Solid Tumors
In a clinical trial, a new class of breast cancer drug called a kinase inhibitor is being tested to treat pancreatic cancer.
New Drug for BRCA Carriers with Advanced Cancer
A phase I clinical trial is testing the effectiveness of a platinum-based drug for BRCA carriers with pancreatic, breast, and other cancers.
New SU2C-Lustgarten Foundation Research Team Aims to Apply CAR T Cell Therapy to Pancreatic Cancer
The approach is called chimeric antigen receptor (CAR) T cell therapy, which uses specially modified immune cells to find and…
Taking Nothing For Granted
After Whipple surgery and chemoradiation for pancreatic cancer, Susan Zbacnik had molecular profiling, genetic testing, and joined vaccine clinical trial.
Electrical Pulses to Destroy Pancreatic Cancer Cells
A clinical trial looks the effectiveness of NanoKnife surgery on pancreatic cancer tumors that cannot be removed by traditional surgery.
Testing Targeted Immunotherapy Against Pancreatic Cancer
Targeted immunotherapy is the focus of a clinical trial that tests the drug ibrutinib, approved for leukemia treatment, against pancreatic cancer.
A Novel Combination to Slow Pancreas Tumors that Cannot Be Surgically Removed
A clinical trial combines standard drugs, a PARP inhibitor, and intensity modulated radiation therapy to slow non-surgical pancreatic tumor growth.
